Thermo Fisher Scientific (MA, USA) are set to acquire Qiagen (Hilden, Germany), a provider of molecular diagnostics and sample preparation technologies, in an $11.5 billion transaction.
BioAgilytix (NC, USA), a provider of large-molecule bioanalytical testing services, has announced the acquisition of the Boston-based CRO, Cambridge Biomedical (MA, USA), which also specializes in large-molecule bioanalysis.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Invicro, an imaging services company, announced the acquisition of Imanova, a UK-based imaging and translational research company.
PerkinElmer aims to expand their reach into the autoimmune and allergy diagnostic market through a $1.3 billion acquisition of EUROIMMUN.
Merger agreement moves closer to completion with the expiration of the Hart-Scott-Rodino Antitrust Improvements Act.
Malvern Instruments Ltd has acquired NanoSight Ltd.